Veterinary Molecular Diagnostics Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2030

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Veterinary Molecular Diagnostics Market Forecast

    4.5. Global Veterinary Molecular Diagnostics Market Outlook

5. Market Outlook

    5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

    5.2. Pet Ownership Statistics

    5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases

    5.4. Covid-19 Impact Analysis

    5.5. Pros and Cons of Each Type of PCR Test

    5.6. Technological Advancement

    5.7. Most commonly Used Instruments for Veterinary Diagnostics

    5.8. Veterinary Medical Device Regulation

6. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

    6.1. Introduction

    6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type

        6.3.1. Instruments & Software

        6.3.2. Kits & Reagents

        6.3.3. Services

    6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type

7. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

    7.1. Introduction

    7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology

        7.3.1. Conventional PCR

        7.3.2. Singleplex PCR

        7.3.3. Multiplex PCR

        7.3.4. Real-time PCR

        7.3.5. Others

    7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology

8. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

    8.1. Introduction

    8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        8.3.1. Vector-borne Diseases

        8.3.2. Respiratory Pathogens

        8.3.3. Diarrhea Pathogens

        8.3.4. Others

    8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

    9.1. Introduction

    9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        9.3.1. Companion Animals

            9.3.1.1. Canine

            9.3.1.2. Feline

            9.3.1.3. Others

        9.3.2. Livestock Animals

    9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type

10. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

    10.1. Introduction

    10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user

        10.3.1. Hospitals/Clinics

        10.3.2. Reference Laboratories

    10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user

11. Global Veterinary Molecular Diagnostics Market Analysis, by Region

    11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country

    11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region

    11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region

        11.3.1. North America

        11.3.2. Europe

        11.3.3. Asia Pacific

        11.3.4. Latin America

        11.3.5. Middle East & Africa

12. North America Veterinary Molecular Diagnostics Market Analysis

    12.1. North America Veterinary Molecular Diagnostics Market Overview

    12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country

    12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country

        12.3.1. U.S.

        12.3.2. Canada

    12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type

        12.5.1. Instruments & Software

        12.5.2. Kits & Reagents

        12.5.3. Services

    12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology

        12.7.1. Conventional PCR

        12.7.2. Singleplex PCR

        12.7.3. Multiplex PCR

        12.7.4. Real-time PCR

        12.7.5. Others

    12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        12.9.1. Vector-borne Diseases

        12.9.2. Respiratory Pathogens

        12.9.3. Diarrhea Pathogens

        12.9.4. Others

    12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        12.11.1. Companion Animals

            12.11.1.1. Canine

            12.11.1.2. Feline

            12.11.1.3. Others

        12.11.2. Livestock Animals

    12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user

        12.13.1. Hospitals/Clinics

        12.13.2. Reference Laboratories

13. Europe Veterinary Molecular Diagnostics Market Analysis

    13.1. Europe Veterinary Molecular Diagnostics Market Overview

    13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        13.3.1. Germany

        13.3.2. U.K.

        13.3.3. France

        13.3.4. Italy

        13.3.5. Spain

        13.3.6. Rest of Europe

    13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type

        13.5.1. Instruments & Software

        13.5.2. Kits & Reagents

        13.5.3. Services

    13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology

        13.7.1. Conventional PCR

        13.7.2. Singleplex PCR

        13.7.3. Multiplex PCR

        13.7.4. Real-time PCR

        13.7.5. Others

    13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        13.9.1. Vector-borne Diseases

        13.9.2. Respiratory Pathogens

        13.9.3. Diarrhea Pathogens

        13.9.4. Others

    13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        13.11.1. Companion Animals

            13.11.1.1. Canine

            13.11.1.2. Feline

            13.11.1.3. Others

        13.11.2. Livestock Animals

    13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user

        13.13.1. Hospitals/Clinics

        13.13.2. Reference Laboratories

14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis

    14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview

    14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        14.3.1. China

        14.3.2. Japan

        14.3.3. India

        14.3.4. Australia & New Zealand

        14.3.5. Rest of Asia Pacific

    14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type

        14.5.1. Instruments & Software

        14.5.2. Kits & Reagents

        14.5.3. Services

    14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology

        14.7.1. Conventional PCR

        14.7.2. Singleplex PCR

        14.7.3. Multiplex PCR

        14.7.4. Real-time PCR

        14.7.5. Others

    14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        14.9.1. Vector-borne Diseases

        14.9.2. Respiratory Pathogens

        14.9.3. Diarrhea Pathogens

        14.9.4. Others

    14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        14.11.1. Companion Animals

            14.11.1.1. Canine

            14.11.1.2. Feline

            14.11.1.3. Others

        14.11.2. Livestock Animals

    14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user

        14.13.1. Hospitals/Clinics

        14.13.2. Reference Laboratories

15. Latin America Veterinary Molecular Diagnostics Market Analysis

    15.1. Latin America Veterinary Molecular Diagnostics Market Overview

    15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        15.3.1. Brazil

        15.3.2. Mexico

        15.3.3. Rest of Latin America

    15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type

        15.5.1. Instruments & Software

        15.5.2. Kits & Reagents

        15.5.3. Services

    15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology

        15.7.1. Conventional PCR

        15.7.2. Singleplex PCR

        15.7.3. Multiplex PCR

        15.7.4. Real-time PCR

        15.7.5. Others

    15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        15.9.1. Vector-borne Diseases

        15.9.2. Respiratory Pathogens

        15.9.3. Diarrhea Pathogens

        15.9.4. Others

    15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        15.11.1. Companion Animals

            15.11.1.1. Canine

            15.11.1.2. Feline

            15.11.1.3. Others

        15.11.2. Livestock Animals

    15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user

        15.13.1. Hospitals/Clinics

        15.13.2. Reference Laboratories

16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis

    16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview

    16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region

        16.3.1. GCC Countries

        16.3.2. South Africa

        16.3.3. Rest of Middle East & Africa

    16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type

    16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type

        16.5.1. Instruments & Software

        16.5.2. Kits & Reagents

        16.5.3. Services

    16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology

    16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology

        16.7.1. Conventional PCR

        16.7.2. Singleplex PCR

        16.7.3. Multiplex PCR

        16.7.4. Real-time PCR

        16.7.5. Others

    16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type

    16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type

        16.9.1. Vector-borne Diseases

        16.9.2. Respiratory Pathogens

        16.9.3. Diarrhea Pathogens

        16.9.4. Others

    16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type

    16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type

        16.11.1. Companion Animals

            16.11.1.1. Canine

            16.11.1.2. Feline

            16.11.1.3. Others

        16.11.2. Livestock Animals

    16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user

    16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user

        16.13.1. Hospitals/Clinics

        16.13.2. Reference Laboratories

17. Competition Landscape

    17.1. Competition Matrix

    17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company

    17.3. Company Profiles

        17.3.1. IDEXX Laboratories, Inc.

            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.1.2. Financial Overview

            17.3.1.3. Product Portfolio

            17.3.1.4. SWOT Analysis

            17.3.1.5. Strategic Overview

        17.3.2. Thermo Fisher Scientific, Inc.

            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.2.2. Financial Overview

            17.3.2.3. Product Portfolio

            17.3.2.4. SWOT Analysis

            17.3.2.5. Strategic Overview

        17.3.3. Zoetis, Inc.

            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.3.2. Financial Overview

            17.3.3.3. Product Portfolio

            17.3.3.4. SWOT Analysis

            17.3.3.5. Strategic Overview

        17.3.4. Neogen Corporation

            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.4.2. Product Portfolio

            17.3.4.3. SWOT Analysis

            17.3.4.4. Strategic Overview

        17.3.5. bioMérieux SA

            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.5.2. Financial Overview

            17.3.5.3. Product Portfolio

            17.3.5.4. SWOT Analysis

            17.3.5.5. Strategic Overview

        17.3.6. QIAGEN N.V.

            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.6.2. Financial Overview

            17.3.6.3. Product Portfolio

            17.3.6.4. SWOT Analysis

            17.3.6.5. Strategic Overview

        17.3.7. Biomedica Medizinprodukte GmbH & Co KG

            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.7.2. Product Portfolio

            17.3.7.3. SWOT Analysis

            17.3.7.4. Strategic Overview

        17.3.8. Bioneer

            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.8.2. Product Portfolio

            17.3.8.3. SWOT Analysis

            17.3.8.4. Strategic Overview

        17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)

            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.9.2. Product Portfolio

            17.3.9.3. SWOT Analysis

            17.3.9.4. Strategic Overview

        17.3.10. ID.VET

            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.10.2. Product Portfolio

            17.3.10.3. SWOT Analysis

            17.3.10.4. Strategic Overview

Report Details

  • Report Code:35970
  • Category:Healthcare
  • No. of Pages:200
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers